Warning: This security is no longer trading.
On December 9, 2021, Thermo Fisher Scientific has concluded its previously announced acquisition of clinical research services provider PPD in a deal valued at $17.4bn in cash, assuming the net debt of nearly $3bn.
PPD Inc. (PPD): Price and Financial Metrics
PPD Price/Volume Stats
| Current price | $47.28 | 52-week high | $47.41 |
| Prev. close | $47.31 | 52-week low | $31.54 |
| Day low | $47.24 | Volume | 2,296,600 |
| Day high | $47.40 | Avg. volume | 1,905,567 |
| 50-day MA | $47.11 | Dividend yield | N/A |
| 200-day MA | $44.84 | Market Cap | 16.61B |
PPD Stock Price Chart Interactive Chart >
PPD Inc. (PPD) Company Bio
Pharmaceutical Product Development LLC is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Its services include contact services, discovery, early development, clinical development, laboratories, post-approval, PPD consulting and industry expertise. The firm operates in the therapeutic areas that include cardiovascular, critical care, dermatology, dental pain research, endocrine and metabolics, gastroenterology, hematology and oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory and urology. The company was founded in 1985 by Fredric N. Eshelman and is headquartered in Wilmington, NC.
PPD Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 0.06% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...